Article Information
History
- December 23, 2020.
Article Versions
- Version 1 (September 18, 2020 - 09:06).
- Version 2 (September 23, 2020 - 11:58).
- Version 3 (September 24, 2020 - 06:39).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Rachel R. Yuen1,
- Dylan Steiner2,
- Erika L. Smith2,
- Riley M.F. Pihl3,
- Elizabeth Chavez2,
- Alex Olson4,
- Lillia A. Baird4,
- Filiz Korkmaz4,
- Patricia Urick4,
- Manish Sagar4,
- Jacob L. Berrigan1,
- Suryaram Gummuluru1,
- Ronald B. Corley1,5,
- Karen Quillen4,
- Anna C. Belkina3,6,
- Gustavo Mostoslavsky7,
- Wenda Gao8,
- Ian Rifkin5,
- Amedeo J. Cappione III9,
- Nina H. Lin4,
- Yachana Kataria6,
- Nahid Bhadelia4,5 and
- Jennifer E. Snyder-Cappione1,3,*
- 1Department of Microbiology; Boston University School of Medicine, Boston, MA, USA
- 2PiBS Program, Boston University School of Medicine, Boston, MA, USA
- 3Flow Cytometry Core Facility, Boston University School of Medicine, Boston, MA, USA
- 4Department of Medicine, Boston University School of Medicine, Boston, MA, USA
- 5National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, USA
- 6Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA
- 7Center for Regenerative Medicine, Boston University School of Medicine, Boston, MA, USA
- 8Antagen Pharmaceuticals, Boston, MA, USA
- 9MilliporeSigma, Burlington, MA, USA
- ↵*Correspondence: Jennifer E. Snyder-Cappione cappione{at}bu.edu